Genmab A (GMAB) Inventory Average (2024 - 2026)

Genmab A has reported Inventory Average for 3 years, with the latest figure at $19.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 550.0% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $19.5 million (up 550.0% YoY), and the FY2025 full-year result was $7.5 million, up 650.0% from the prior year.
• Inventory Average for Q1 2026 stood at $19.5 million, up from $6.5 million in the prior quarter.
• The five-year high for Inventory Average was $19.5 million in Q1 2026, with the low at -$4.5 million in Q3 2025.
• Historically, Inventory Average has averaged $2.6 million across 3 years, with a median of $500000.0 in 2024.
• Annual changes were most pronounced in 2025 — Inventory Average tumbled 1000.0% — and 2026, when it surged 550.0%.
• Genmab A's Inventory Average stood at $3.5 million in 2024, then jumped by 85.71% to $6.5 million in 2025, then surged by 200.0% to $19.5 million in 2026.
• The last three Inventory Average figures came in at $19.5 million (Q1 2026), $6.5 million (Q4 2025), and -$4.5 million (Q3 2025), per Business Quant data.